Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

Stenson, Kerstin

One or more keywords matched the following items that are connected to Stenson, Kerstin

Item Type	Name
Concept	Radiotherapy Dosage
Academic Article	Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.
Academic Article	Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.
Academic Article	Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy.
Academic Article	Planned post-chemoradiation neck dissection: significance of radiation dose.
Academic Article	Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions.
Academic Article	High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trial.
Academic Article	Efficacy and safety of treating T4 oral cavity tumors with primary chemoradiotherapy.
Academic Article	Chemoradiotherapy for locoregionally advanced squamous cell carcinoma of the base of tongue.
Academic Article	Chemoreirradiation for recurrent salivary gland malignancies.
Academic Article	Airway management before chemoradiation for advanced head and neck cancer.
Academic Article	Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation.
Academic Article	Chemoradiation for patients with large-volume laryngeal cancers.
Academic Article	Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer.
Academic Article	Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer.
Academic Article	Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer.
Academic Article	Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primary.
Academic Article	Functional organ preservation with definitive chemoradiotherapy for T4 laryngeal squamous cell carcinoma.
Academic Article	A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancers.
Academic Article	Outcomes of induction chemotherapy followed by concurrent chemoradiation for nasopharyngeal carcinoma.

Search Criteria

Radiotherapy Dosage